ClinicalTrials.gg
Not yet recruitingNCT07907458Updated Oct 30, 2026

Digital Use, 24-Hour Movement Behaviors, and Myofascial Release in University Students With Neck Pain

An interventional study of Integrated Myofascial Release and Light-Touch Control in Forward Head Posture and Chronic Nonspecific Neck Pain, sponsored by Karabuk University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Karabuk University · Not applicable, Interventional, and Treatment

Updated Oct 30, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

This study will examine how smartphone use recorded by the phone and daily sleep, sitting, and physical activity are related to neck posture, sensitivity to pressure, and body awareness in university students aged 18 to 30 years. One hundred students will complete seven days of smartphone and activity monitoring and clinical assessments. Among these students, 56 who have nonspecific neck pain for at least three months, average pain of at least 3 out of 10, and forward head posture will be randomly assigned to integrated myofascial release or a light-touch control. Both groups will receive six sessions over two weeks. An assessor who does not know the assigned group will measure outcomes before and after treatment and, where feasible, one month after treatment. The study will investigate whether myofascial release improves neck pain, pressure pain threshold, posture, movement, disability, and awareness.

Read the detailed description

This single-center prospective study at Karabuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, includes an observational assessment of 100 university students and an embedded assessor-blinded, parallel-group randomized controlled trial involving 56 eligible participants (28 per group). The interventional enrollment target is 56; the wider observational sample is 100 and is not an additional randomized arm.

Smartphone use will be recorded for seven consecutive days using Screen Time, Digital Wellbeing, or an equivalent device-based system. No message contents, contacts, photographs, passwords, or personal files will be collected. During the same period, a triaxial accelerometer will estimate sleep, sedentary behavior, light physical activity, and moderate-to-vigorous physical activity. Device placement, valid-day criteria, and processing will be standardized using a validated protocol for the selected device before data collection.

Cervical posture will be assessed with standardized lateral photogrammetry using the tragus and C7 to calculate craniovertebral angle. During a 20-minute standardized smartphone task, angle will be recorded at the start, 10 minutes, and 20 minutes. Clinical assessments include digital algometry, numerical pain ratings, cervical range of motion, the Turkish Body Awareness Questionnaire, Fremantle Neck Awareness Questionnaire, and Neck Disability Index.

Participants eligible for the randomized component will be allocated 1:1 using a computer-generated sequence with concealment by an independent person using sealed opaque envelopes or an equivalent secure method. Integrated myofascial release targets cervical-related structures including the suboccipital region, upper trapezius, levator scapulae, and sternocleidomastoid. Six sessions will be administered over two weeks. Control participants receive light manual contact in comparable positions for a comparable duration without targeted fascial stretching or therapeutic pressure. Outcomes are assessed before treatment, after six sessions, and where feasible at one month after treatment. Discomfort and adverse events will be recorded at each session.

Associations will be examined using correlations and multivariable regression. Twenty-four-hour movement behaviors will be analyzed as compositional data. Randomized outcomes will be analyzed using mixed-effects models with group, time, and group-by-time interaction, following the intention-to-treat principle. Effect sizes and 95% confidence intervals will be reported. Data collection will not begin before ethics approval and institutional permissions are in place.

02

Conditions studied

  • Forward Head Posture
  • Chronic Nonspecific Neck Pain
03

In context

Lead sponsor

Karabuk University is the lead sponsor of 142 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • University student aged 18 to 30 years.
  • Regular smartphone use and willingness to complete seven-day device-based smartphone and accelerometer monitoring.
  • Written informed consent.
  • For the randomized intervention: nonspecific neck pain for at least three months; average neck pain during the previous week of at least 3 on a 0-10 numerical rating scale; and craniovertebral angle of 50 degrees or less on standardized lateral photogrammetry.

Exclusion criteria

Exclusion Criteria:

  • Acute cervical trauma or history of cervical spine surgery.
  • Neurological, inflammatory rheumatic, or specific orthopedic disease substantially affecting cervical posture or movement.
  • Any condition preventing safe completion of monitoring or clinical assessments.
  • For the randomized intervention: signs of cervical radiculopathy, myelopathy, or specific cervical pathology, or recent cervical manual therapy or physiotherapy.

The wider observational assessment includes 100 students with or without neck pain; only 56 students meeting the additional neck-pain and posture criteria enter this randomized interventional record.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
56 participants (estimated)

Study arms

  • Experimental
    Integrated Myofascial Release

    Twenty-eight participants receive integrated myofascial release targeting the suboccipital region, upper trapezius, levator scapulae, and sternocleidomastoid. Six sessions are delivered by a trained physiotherapist, three sessions per week for two weeks, using a standardized sequence and duration.

    Other: Integrated Myofascial Release

  • Sham comparator
    Light-Touch Control

    Twenty-eight participants receive light manual contact without targeted myofascial stretching or therapeutic pressure, in positions and for a duration comparable to the intervention group. Six sessions are delivered over two weeks, three sessions per week.

    Other: Light-Touch Control

Interventions

  • OtherIntegrated Myofascial Release

    Manual myofascial release of cervical-related structures, including the suboccipital region, upper trapezius, levator scapulae, and sternocleidomastoid, delivered by a trained physiotherapist in a standardized sequence. Three sessions per week for two weeks (six sessions).

  • OtherLight-Touch Control

    Light manual contact in positions and for a duration comparable to myofascial release, without targeted fascial stretching or therapeutic pressure. Three sessions per week for two weeks (six sessions).

06

What researchers measure

Primary outcomes

  1. Change in Pressure Pain Threshold

    Pressure pain threshold measured with a digital algometer with a 1 cm2 probe at standardized cervical muscle sites. Repeated measurements at each site are averaged and reported in kPa. A higher threshold indicates lower mechanical pain sensitivity. The primary comparison is baseline to completion of six sessions.

    Time frame: Baseline and immediately after six sessions (2 weeks)

Secondary outcomes

  1. Change in Craniovertebral Angle

    Craniovertebral angle in degrees measured by standardized lateral photogrammetry using the tragus and C7. A larger angle indicates less forward head posture. Assessed at the start, 10 minutes, and 20 minutes of a standardized smartphone task.

    Time frame: Baseline, immediately after six sessions (2 weeks), and 1 month after treatment (approximately week 6), where feasible

  2. Change in Neck Pain Intensity

    Average neck pain over the preceding week measured using a 0-10 Numerical Rating Scale, where 0 means no pain and 10 means the worst imaginable pain. Lower scores indicate less pain.

    Time frame: Baseline, immediately after six sessions (2 weeks), and 1 month after treatment (approximately week 6), where feasible

  3. Change in Cervical Range of Motion

    Active cervical flexion, extension, right and left rotation, and right and left lateral flexion measured in degrees using a clinical range-of-motion device or digital inclinometer. Each direction is analyzed separately.

    Time frame: Baseline, immediately after six sessions (2 weeks), and 1 month after treatment (approximately week 6), where feasible

  4. Change in Neck Disability Index

    Turkish Neck Disability Index: 10 items, each scored 0-5; total 0-50. Higher scores indicate greater neck-related disability.

    Time frame: Baseline, immediately after six sessions (2 weeks), and 1 month after treatment (approximately week 6), where feasible

  5. Change in Body Awareness

    Turkish Body Awareness Questionnaire assesses awareness of bodily processes and responses. Eighteen items rated 1-7 yield a total of 18-126, with higher scores indicating greater body awareness.

    Time frame: Baseline, immediately after six sessions (2 weeks), and 1 month after treatment (approximately week 6), where feasible

  6. Change in Neck Awareness

    Turkish Fremantle Neck Awareness Questionnaire: nine items scored 0-4, total 0-36. Higher scores indicate greater disturbance of neck-related perception.

    Time frame: Baseline, immediately after six sessions (2 weeks), and 1 month after treatment (approximately week 6), where feasible

  7. Pressure Pain Threshold at Follow-up

    Digital algometry at the same standardized cervical sites used at baseline, with repeated measurements averaged and reported in kPa; higher values indicate lower mechanical pain sensitivity.

    Time frame: Baseline and 1 month after completion of treatment (approximately week 6), where feasible

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Oct 2027, 11 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 24, 2026
First posted
Oct 30, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Oct 31, 2027
CompletionEst.
Oct 31, 2027
Last update
Oct 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07907458
Lead sponsor
Karabuk University
Responsible party
Ece ACAR (Assistant Professor, Principal Investigator, Karabuk University) — Principal investigator
First posted
Oct 30, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Oct 31, 2027 (estimated)
Completion
Oct 31, 2027 (estimated)
Last update
Oct 30, 2026

Study contacts

Ece Acar, PhD, PT
Contact
eceacar@karabuk.edu.tr
+905457925035
Ece Acar, PhD, PT
principal investigator · Karabuk University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion